Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Adenocarcinoma of Prostate

Tundra lists 3 Adenocarcinoma of Prostate clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT04687969

Multimodal Machine Learning Characterization of Solid Tumors

This research study wants to develop advanced imaging methods to more accurately characterize prostate cancer or solid tumor aggressiveness. This observational study involves \[18F\]DCFPyL positron emission tomography and magnetic resonance imaging (PET/MRI)

Gender: All

Ages: 18 Years - Any

Updated: 2025-09-25

1 state

Adenocarcinoma of Prostate
Radical Prostatectomy
Hepatocellular Carcinoma (HCC)
+3
ACTIVE NOT RECRUITING

NCT01952223

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

The objective of this study is to assess the effect of neoadjuvant cabazitaxel and pelvic radiotherapy in combination with androgen deprivation therapy (ADT)-radiotherapy on clinical progression-free survival in patients with high-risk localized prostate cancer (with a stringent selection of patients with at least 2 high-risk features), in a 2 by 2 factorial trial.

Gender: MALE

Ages: 18 Years - 75 Years

Updated: 2025-07-30

Adenocarcinoma of Prostate
Progression of Prostate Cancer
ACTIVE NOT RECRUITING

NCT01994239

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

The purpose of this study is to select the best therapeutic strategy in studying the effectiveness of the association of a short duration hormonal therapy and radiotherapy compared with radiotherapy alone, in patients with a detectable PSA after radical prostatectomy.

Gender: MALE

Ages: 18 Years - Any

Updated: 2024-12-16

Adenocarcinoma of Prostate